Clinical trials
Observational Pulmonary Arterial Hypertension trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 4 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2017 | 2 |
| 2021 | 1 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 10 |
| Not yet recruiting | 2 |
| Unknown status | 2 |
| Enrolling by invitation | 1 |
| Recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assistance Publique - Hôpitaux de Paris | 5 |
| Central Hospital, Nancy, France | 2 |
| Groupe d'Etudes et de Recherche sur les Maladies Orphelines Pulmonaires | 2 |
| AOP Orphan Pharmaceuticals AG | 1 |
| Association de Recherche en Physiopathologie Respiratoire | 1 |
| Bayer | 1 |
| Centre Hospitalier Universitaire de Nice | 1 |
| Centre Hospitalier Universitaire de Saint Etienne | 1 |
| Pfizer | 1 |
| Poitiers University Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pulmonary Arterial Hypertension | 17 |
| Hypertension, Pulmonary | 4 |
| Cystic Fibrosis | 1 |
| Dyspnea | 1 |
| Heart Failure | 1 |
| Neoplasm Metastasis | 1 |
| Pulmonary Disease, Chronic Obstructive | 1 |
| Rare Diseases | 1 |
| Sleep Apnea Syndromes | 1 |
| Sleep Wake Disorders | 1 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.